Alpharadin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The administration of a radionuclide in unsealed source whose radiation will destroy cells that have selectively accumulated…
Abstract: Castration-resistant prostate cancer (CRPC) has a poor prognosis and remains a significant therapeutic challenge…
Background Radium-223 (Alpharadin™) is a 1st-in-class alpha-pharmaceutical. It targets bone metastases (mets) with high-energy…
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC
A central theme in radiation therapy of cancer is…
• The overall adverse event profile was consistent with that expected for patients undergoing treatment for advanced cancer with…
Bayer and Algeta have entered into a deal to promote Algeta's novel alpha-ray emitting pharmaceutical based on radium-223 called…